Concepedia

Laura Reebel

LR

3

Publications

321

Citations

3

H-Index

2014

Active since

Affiliations

The Ohio State University(Current)

University of California, San Francisco

Oregon Health & Science University

Plexxikon (United States)

Case Western Reserve University

Laura Reebel is an author at The Ohio State University specializing in oncology, medicine, and tumor immunity.

Top concepts

Publications per year

2014–2019

3

Publications

3

Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors

Robert Wesolowski, Neelesh Sharma, Laura Reebel et al. · Therapeutic Advances in Medical Oncology · 2019 · 161 citations · Full text

Primary Results of the Multicenter ARISE II Study (Analysis of Revascularization in Ischemic Stroke With EmboTrap)

Osama O. Zaidat, Hormozd Bozorgchami, Marc Ribó et al. · Stroke · 2018 · 149 citations · Full text

A phase 1b study to assess the safety of PLX3397, a CSF-1 receptor inhibitor, and paclitaxel in patients with advanced solid tumors.

Neelesh Sharma, Robert Wesolowski, Laura Reebel et al. · Journal of Clinical Oncology · 2014 · 11 citations

, , +20

Rows per page

1–3 of 3